RM Partners

Pancreatic and bile duct cancer have the worst outlook of any cancer but the slowest diagnosis given their location deep in the body. The current pathway relies on invasive biopsies to diagnose these cancers. This pathway is slow, with some patients having repeated procedures to get a diagnosis, often resulting in delays to patients starting treatment.

A liquid biopsy is a non-invasive blood test which can be used to detect tumour DNA in the blood of patients with suspected pancreatic and biliary tract cancers. We will add liquid biopsies into the current diagnostic pathway, to cut through major bottlenecks and enable patients to access treatment earlier.